Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs.

Authors :: Kooiman J
van de Peppel WR
van der Meer FJ
Huisman MV
Source :: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2011 Aug; Vol. 9 (8), pp. 1652-3.
Publication Year :: 2011

Subjects :: Administration, Oral
Atrial Fibrillation epidemiology
Benzimidazoles adverse effects
Benzimidazoles pharmacokinetics
Biomarkers blood
Chronic Disease
Creatinine blood
Dabigatran
Fibrinolytic Agents adverse effects
Fibrinolytic Agents pharmacokinetics
Glomerular Filtration Rate
Humans
Incidence
Kidney metabolism
Kidney physiopathology
Kidney Diseases diagnosis
Kidney Diseases metabolism
Kidney Diseases physiopathology
Morpholines adverse effects
Morpholines pharmacokinetics
Netherlands epidemiology
Patient Selection
Retrospective Studies
Risk Assessment
Risk Factors
Rivaroxaban
Severity of Illness Index
Thiophenes adverse effects
Thiophenes pharmacokinetics
beta-Alanine administration & dosage
beta-Alanine adverse effects
beta-Alanine pharmacokinetics
Atrial Fibrillation drug therapy
Benzimidazoles administration & dosage
Fibrinolytic Agents administration & dosage
Kidney Diseases epidemiology
Morpholines administration & dosage
Thiophenes administration & dosage
beta-Alanine analogs & derivatives

Full Text Access

Tools